Skip to main content

Ph III study to evaluate the safety of ALN-TTR02 in TTR-Medicated Polyneuropathy

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Alnylam Pharmaceuticals

Start Date

November 1, 2014

End Date

August 2, 2018
 

Administered By

Duke Cancer Institute

Awarded By

Alnylam Pharmaceuticals

Start Date

November 1, 2014

End Date

August 2, 2018